SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-012450
Filing Date
2020-02-07
Accepted
2020-02-07 14:42:45
Documents
6
Period of Report
2020-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206981-1_8k.htm 8-K 22961
2 EXHIBIT 2.1 tm206981d1_ex2-1.htm EX-2.1 434036
3 EXHIBIT 99.1 tm206981d1_ex99-1.htm EX-99.1 11998
4 GRAPHIC tm206981d1_ex99-1img001.jpg GRAPHIC 9768
5 GRAPHIC tm206981d1_ex99-1img002.jpg GRAPHIC 9076
6 GRAPHIC tm206981d1_ex99-1img003.jpg GRAPHIC 2706
  Complete submission text file 0001104659-20-012450.txt   500447
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 20586872
SIC: 2834 Pharmaceutical Preparations